17.11.2012
- The U.S. Federal Trade Commission has cleared Valeant Pharmaceuticals International's $2.6 billion deal to buy U.S. dermatology rival Medicis Pharmaceutical, without conditions...
16.11.2012
- When Sanofi boss Chris Viehbacher first met staff at Genzyme, the U.S. biotech he had just acquired after a long takeover battle, he told them he did not want "planeloads of people...
02.11.2012
- European officials have approved the Western world's first gene therapy drug from a small Dutch biotech company, in a milestone for the novel medical technology that fixes faulty...
01.11.2012
- Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators...
31.10.2012
- French oil company Total reported a 20% rise in third-quarter net adjusted profit to €.348 billion on Wednesday, beating analysts' expectations thanks to a sharp increase in...
25.10.2012
- French drugmaker Sanofi forecast 2012 earnings would fall less than expected as cost cuts and demand for diabetes and rare disease drugs cushion the blow from patent expiries...
17.10.2012
- U.S. drug reviewers flagged several safety concerns, including possible cancer risks, related to Sanofi and Isis Pharmaceuticals's lipid disorder drug Kynamro, sending Isis's...
03.10.2012
- Drugmakers Sanofi and Bristol-Myers Squibb plan to revamp their 15-year-old alliance from Jan. 1 in response to lost exclusivity on two key drugs and the arrival of generic...
02.10.2012
- Giant French pharmaceutical maker Sanofi said Tuesday it would buy Colombian drugmaker Genfar to expand its product portfolio in South America. Genfar is Colombia's second-largest...
01.10.2012
- Sanofi is pleased to announce today the appointment of Dr. Paul Chew, Senior Vice President, Chief Medical Officer and Head of Global Medical Affairs as of January 1, 2013. Dr...